Marc Derive
CHIEF SCIENTIFIC OFFICER
Biopharmaceutical
INOTREM
France
Biography
Dr. Marc Derive, PhD, is the co-founder and Chief Scientific Officer of INOTREM. After successfully completing a Master of Business and Engineering, he joined the team of Pr Sébastien Gibot in 2007 to complete a PhD in immunology and a post-doctoral fellowship at the University of Lorraine, France. He worked on the role of TREM-1 in the pathogenesis of septic shock and other acute and chronic inflammatory conditions. Marc Derive completed his scientific background with education in business and administration at HEC business school (Paris). His work has led to the development of TREM-1 inhibitor drug candidates, 4 patents, several publications and the creation of INOTREM in 2013.
Research Interest
Pathogenesis of septic shock and other acute and chronic inflammatory conditions
